Clinical Trials Sponsored by The Affiliated Tumor Hospital of Guangxi Medical University

Total 2050 results

First Affiliated Hospital of Guangxi Medical University

Recruiting

Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM

Type2diabetes

China
First Affiliated Hospital of Guangxi Medical University

Completed

Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder

NMO Spectrum Disorder | Azathioprine Adverse Reaction

China
First Affiliated Hospital of Guangxi Medical University

Unknown

Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism

Beta Thalassemia Major

China
First Affiliated Hospital of Guangxi Medical University

Unknown

Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
First Affiliated Hospital of Guangxi Medical University

Unknown

Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer

Esophageal Cancer
First Affiliated Hospital of Guangxi Medical University

Unknown

A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma

Biliary Carcinoma

China
First Affiliated Hospital of Guangxi Medical University

Unknown

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
First Affiliated Hospital of Guangxi Medical University

Recruiting

The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer

Rectal Cancer | Rectal Cancer Stage II | Rectal Cancer Stage III

China
First Affiliated Hospital of Guangxi Medical University

Recruiting

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

Colonic Neoplasms | Neoadjuvant Therapy | Immune Checkpoint Inhibitors

China
First Affiliated Hospital of Guangxi Medical University

Recruiting

Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Hepatocellular Carcinoma Non-resectable | Immune Checkpoint Inhibitors | Portal Vein Tumor Thrombus

China
First Affiliated Hospital of Guangxi Medical University

Recruiting

CRUSTAL Study in China

Coronary Artery Disease | Calcification

China
Fourth Affiliated Hospital of Guangxi Medical University

Recruiting

Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer

Uterine Cervical Neoplasms | Adjuvant Chemotherapy | Chemoradiotherapy

China
Second Affiliated Hospital of Guangxi Medical University

Not yet recruiting

Safety and Efficacy of Evolocumab in Ischemic Stroke (SEEIS)

Ischemic Stroke, Acute
First Affiliated Hospital of Guangxi Medical University

Recruiting

Edaravone in the Treatment of Aquaporin-4 Antibody-positive Optic Neuritis

Optic Neuritis

China
First Affiliated Hospital of Guangxi Medical University

Recruiting

Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer

Cervical Cancer

China
First Affiliated Hospital of Guangxi Medical University

Completed

Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
First Affiliated Hospital of Guangxi Medical University

Terminated

Gypenosides Treatment for Optic Neuritis

Optic Neuritis

China
First Affiliated Hospital of Guangxi Medical University

Unknown

Anlotinib Plus Docetaxel for the Treatment of EGFR/ALK/ROS1 Mutation-negative Advanced Nonsquamous NSCLC

Non-small Cell Lung Cancer
First Affiliated Hospital of Guangxi Medical University

Unknown

Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major

Thalassemia Major

China
Sun Yat-sen University
Zhejiang Cancer Hospital; Fifth Affiliated Hospital, Sun Yat-Sen University; Guangzhou... and other collaborators

Unknown

Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer (DP-EN-RT)

Non-small Cell Lung Cancer

China
Second Affiliated Hospital, School of Medicine,...
The First Affiliated Hospital of Zhengzhou University; The Affiliated Tumor...

Recruiting

Lenvatinib, Tislelizumab Combined With Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma

Advanced Cholangiocarcinoma

China
Bioray Laboratories
First Affiliated Hospital of Guangxi Medical University

Not yet recruiting

Clinical Study of BRL-101 in Severe SCD

Sickle Cell Disease

China
Bioray Laboratories
First Affiliated Hospital of Guangxi Medical University

Suspended

Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells

Thalassemia Major

China
People's Hospital of Guangxi
Liuzhou Workers Hospital; Cancer Hospital of Guangxi Medical University; First... and other collaborators

Not yet recruiting

Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma

Glioblastoma

China
Guangxi Medical University
Guilin Medical College; Second Affiliated Hospital of Guangzhou Medical University and other collaborators

Unknown

Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole Therapy (CSHHTVASIT)

Talaromyces in Human Immunodeficiency Virus Negative | To Compare Voriconazole and Amphotericin Sequential Itraconazole Therapy | To Dynamically Monitor the Anti-Interferon-γ Autoantibodies

China
Zhujiang Hospital
The First Affiliated Hospital of Anhui Medical University; The First Affiliated... and other collaborators

Unknown

Transurethral Plasmakinetic Enucleation of Prostate Versus Transurethral Resection of Prostate (ERP)

Benign Prostatic Hyperplasia

China
Sun Yat-sen University
Cancer Hospital of Guangxi Medical University; First Affiliated Hospital of... and other collaborators

Enrolling by invitation

Treatments for Brain Metastases With Poor Prognostic Factors (TBMPPF)

Brain Metastases

China
RenJi Hospital
Shanghai Tong Ren Hospital; The First Affiliated Hospital of Zhengzhou University and other collaborators

Recruiting

Effect of Nalmefene on the Quality of Resuscitation in Patients Under General Anesthesia

Resuscitation

China
First Affiliated Hospital of Guangxi Medical University
Genmedicn Biopharma Ltd.

Recruiting

A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemia Participants

Transfusion-dependent α-Thalassemia

China
First Affiliated Hospital of Guangxi Medical University
Peking University People's Hospital; Ruijin Hospital; The Affiliated Hospital... and other collaborators

Recruiting

Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study

Thalassemia Major

China
First Affiliated Hospital of Guangxi Medical University
Genmedicn Biopharma Ltd.

Recruiting

A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]

Transfusion Dependent Beta-Thalassemia

China
Yong Zhang,MD

Recruiting

Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Uterine Cervical Neoplasms

China
Yong Zhang,MD

Unknown

Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma (ECWHCCFLACC)

Cervical Carcinoma

China
Affiliated Hospital of Nantong University
The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province...

Recruiting

A Real World Study of Camrelizumab in the Treatment of Advanced Non-squamous Non-small-cell Lung Cancer

Lung Cancer

China
Yong Zhang,MD

Recruiting

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer

Rectal Neoplasms

China
First Affiliated Hospital of Guangxi Medical University
Zhejiang Cancer Hospital; Xiangya Hospital of Central South University; Shandong... and other collaborators

Not yet recruiting

Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Guangxi Medical University
Guilin Medical College; Second Affiliated Hospital of Guangzhou Medical University and other collaborators

Unknown

Retrospective Analysis of the Epidemiological Change and Determinants of Prognosis of Talaromycosisof Human Immunodeficiency Virus Negative Host in Guangxi (RAECDPT)

To Investigate the Characteristics and Prognostic Factors of T. Marneffei Infections and the Causes of Misdiagnosis | To Study the Recurrence Indicators and Establish a Therapeutic Effect Evaluation System of T. Marneffei Infections

China
Guangxi Medical University
Second Affiliated Hospital of Guangxi Medical University; Guilin Medical University... and other collaborators

Unknown

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Nasopharyngeal Cancer | Nasopharynx Cancer
Guohua Zeng
The First Affiliated Hospital of Nanchang University; Henan Provincial People... and other collaborators

Recruiting

Treatment of Upper Urinary Tract Stones With a Diameter≤2cm by Intelligent Pressure-controlled Flexible Ureteroscope

Urinary Calculi

China
CorrectSequence Therapeutics Co., Ltd
First Affiliated Hospital of Guangxi Medical University

Recruiting

A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia

Beta-Thalassemia

China
Fudan University
The First Affiliated Hospital of Xiamen University; Fujian Province Tumor Hospital

Completed

Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC

Nasopharyngeal Carcinoma

China
China Medical University, China
The People's Hospital of Liaoning Province; The First Affiliated Hospital of... and other collaborators

Not yet recruiting

Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients

Colorectal Neoplasms | Regorafenib | Raltitrexed | Third-line Treatment
Affiliated hospital of guangxi medical university...
Zhongshan Hospital Xiamen University; The Affiliated Nanjing Drum Tower Hospital... and other collaborators

Unknown

Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major

Beta-Thalassemia Major

China
CorrectSequence Therapeutics Co., Ltd
First Affiliated Hospital of Guangxi Medical University

Not yet recruiting

A Clinical Trial Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia

Beta-Thalassemia

China
Second Affiliated Hospital of Guangxi Medical University
CSPC Pharmaceutical Group Limited

Not yet recruiting

Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke (ATTIS)

Acute Ischemic Stroke
Sun Yat-sen University
First People's Hospital of Foshan; Affiliated Cancer Hospital & Institute of... and other collaborators

Unknown

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Simcere Pharmaceutical Co., Ltd
The Affiliated Changzhou Tumor Hospital of Suzhou University

Unknown

FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer

Colorectal Neoplasms

China
Sun Yat-sen University
Wuhan University; Tongji Hospital; Hunan Province Tumor Hospital; Second Affiliated... and other collaborators

Recruiting

Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma (IMRT)

Nasopharyngeal Carcinoma

China
China Medical University, China
General Hospital of Shenyang Military Region; Shengjing Hospital; The People's... and other collaborators

Unknown

Apatinib Plus Irinotecan as Second-line Treatment in AGC or EGJA

Metastatic Gastric Adenocarcinoma

China
Zhujiang Hospital
Sun Yat-sen University; Ludwig-Maximilians - University of Munich; The Third... and other collaborators

Recruiting

Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder

Bladder Cancer | Urinary Diversion

China

Clinical Trials Sponsored by The Affiliated Tumor Hospital of Guangxi Medical University

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations